Navigation Links
Long-term Follow Up Interim Data Show Nplate(TM) Increased and Sustained Platelet Counts in Adult Chronic ITP Patients
Date:12/8/2008

SAN FRANCISCO, Dec. 8 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today released updated results from the ongoing, open-label extension study of the long-term safety and efficacy of Nplate(TM) (romiplostim) in adult patients with chronic immune thrombocytopenic purpura (ITP). Chronic ITP is a chronic and serious autoimmune disorder characterized by lower than expected platelet counts in the blood, sometimes leading to serious bleeding events. The results were presented today as an oral presentation at the 50th Annual Meeting of the American Society of Hematology (ASH Abstract # 402). Results from a study of Nplate in myelodysplastic syndromes (MDS) also were presented.

"These data show Nplate increased platelet counts in most patients for most of the time, and clinically relevant bleeding was reduced over time," said David J. Kuter, M.D., Chief of Hematology, Massachusetts General Hospital, Boston. "This is significant because Nplate can be a long-term treatment for adult chronic ITP patients, who are at risk of serious bleeding events if their platelet counts drop to less than 30,000 per microliter. These patients have had limited availability to long term treatment options."

These study results showed that overall 74 percent of patients (160/215) achieved a platelet response defined as a platelet count of 50,000 platelets per microliter and doubling of the baseline platelet count (median:17,000 platelets per microliter). A platelet response was achieved by 30 percent (61/207) of patients after the first dose and by 47 percent (94/199) of patients after the third dose. The average treatment period was 76 weeks and the longest duration of treatment was 204 weeks.

Additional key findings from the Extension study show:

-- Platelet counts increased: Platelet counts of Nplate-treated pati
'/>"/>

SOURCE Amgen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. GSK Reports PROMACTA(R) (eltrombopag) Significantly Increased Platelet Counts and Reduced Bleeding in Long-Term Study of Patients With Chronic ITP
2. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
3. Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
4. Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults
5. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
6. Continuous Treatment With Abbotts HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
7. Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain
8. Medivation Presents Positive New Data on Dimebons Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimers Disease
9. Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success
10. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
11. Patients Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Calif. , March 30, 2015  Cochlear ... has decided to leave Cochlear to join Valencia ... and friend, Jeff Greiner , who is ... Chief of Market Development and will be responsible ... of Valencia,s coin-sized neuromodulation ...
(Date:3/30/2015)...  Edison Nation Medical, the premier healthcare innovation ... innovations to assist seniors in staying mobile and ... 8-week search will be presented to major medical ... be submitted through a secure, confidential portal at ... The objective of the Senior Mobility ...
(Date:3/30/2015)... DURECT Corporation (Nasdaq: DRRX ) ... Phase 1 clinical trial of an oral formulation ... Regulator Program.  DUR-928 is an endogenous, small-molecule, new ... in metabolic diseases such as nonalcoholic fatty liver ... also play an important role in protecting against ...
Breaking Medicine Technology:Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4
... LAKES, N.J., Jan. 4, 2011 BD (Becton, Dickinson and Company) ... announced today that it will present at the 29th Annual J. ... p.m. (ET). A live webcast of BD,s presentation ... and will be available for replay through Monday, January 17, ...
... (Nasdaq: ERES ), announced today that Dr. Joel ... Company,s Chief Financial Officer, are scheduled to present at the ... on January 13, 2011 in San Francisco, California. ... corporate website at http://www.ert.com . The webcast may also ...
Cached Medicine Technology:ERT to Present at the 29th Annual J.P. Morgan Healthcare Conference on January 13, 2011 2
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 Foundations ... proud to announce the start of its 41st national ... author Jane McGonigal, and former Congressman Patrick J. Kennedy ... Conference being held in San Diego, CA, March ... Coronado. The national conference brings together leading experts specializing ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 The Consumer Attorneys ... Skills for the New Attorney” seminar for attorneys who passed ... brings top trial attorneys in the Southern California area to ... Doctors on Liens was on hand, not ... to the doctors their clients will need to help in ...
(Date:3/30/2015)... March 30, 2015 KIND LED’s suite of ... light products in 2015. The excellent value and product features ... take the pole position in the race for the best ... the KIND LED suite of grow lights is the ... Photosynthetic Active Radiation (PAR) wavelengths that plants are most likely ...
(Date:3/30/2015)... Healtheminds, a start-up focusing on providing high ... easy to use and engaging online platform, is launching ... health related issues. The first in the series is ... other drugs. , Consumption and use of alcohol ... the toxic effects of excessive intake or drug overdoses, ...
(Date:3/30/2015)... 2015 Dr. Jeffrey Allred DDS, with his ... minute second opinion consultations for patients who need ... on dental second opinions show how small percentage of dentistry ... works. Only 6%” – says Dr. Allred. , “People ... fully trusting the dental care provider, for the simple fact ...
Breaking Medicine News(10 mins):Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 2Health News:Doctors on Liens Sponsors New Personal Injury Attorneys in Los Angeles 3Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2
... Cancer Center researchers have identified a new population of intestinal ... colorectal cancer. , This new stem cell population, reported March ... relatively quiescent (inactive) in contrast to the recent discovery ... marked by a protein, Lrig1, that may act as a ...
... Ill. -- The American Society for Gastrointestinal Endoscopy (ASGE) ... program specifically dedicated to promoting quality in endoscopy, in ... States. The ASGE Endoscopy Unit Recognition Program honors endoscopy ... assurance, endoscope reprocessing and CDC infection control guidelines. To ...
... News) -- Tourists over age 65 who visit malaria-infested regions are ... those ages 18 to 35, a new study says. The ... patients also found that the malaria death rate is particularly high ... of dying from malaria, an infection carried by mosquitoes, increased with ...
... with intensity modulated radiation therapy (IMRT) instead of standard ... acute or chronic toxicities, according to a study in ... official clinical practice journal of the American Society for ... determine the most effective breast cancer treatment that also ...
... 27 (HealthDay News) -- Women with ovarian cancer who ... have annual incomes of less than $35,000 are more ... Researchers found these racial and socioeconomic disparities in ... of surviving for five years after their cancer diagnosis. ...
... have identified genetic causes in nearly 1 in 5 patients ... Carolyn Jones, MD, PhD, of Loyola University Medical Center, ... of Cardiac Failure . First author is Neal Lakdawala, MD, ... on 264 patients with dilated cardiomyopathy and found that 17.4 ...
Cached Medicine News:Health News:Newly identified stem cells may hold clues to colon cancer 2Health News:ASGE recognizes 18 endoscopy units for quality 2Health News:Older Travelers at Much Higher Risk of Dying From Malaria 2Health News:IMRT reduces risk of side effects in breast cancer patients 2Health News:Black Women, Uninsured Get Worse Ovarian Cancer Care: Study 2Health News:Genetic causes found in nearly 1 in 5 patients with dilated cardiomyopathy heart failure 2
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
The 5524-7.5 linear transducer is a high frequency transducer dedicated to superficial and vascular imaging....
The 9114-3.5 transducer is a versatile general imaging transducer. With multifrequencies, this transducer provides superb image quality and meets a multitude of imaging needs....
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Medicine Products: